Clinical trials recruiting for Seizures

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
  NCT05140265 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ear-Seizure Detection (EarSD) Study
  NCT06598189 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
  NCT07072624 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations
• Etiology and Treatment of Neonatal Seizure
  NCT03822741 · Phase: Not specified · Ages: Up to 12 Months · Sex: All (male and female) · 1 location
• Genetic Markers of Cardiovascular Disease in Epilepsy
  NCT02824822 · Phase: Not specified · Ages: 18 Years to 50 Years · Sex: All (male and female) · 1 location
• Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
  NCT06027749 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · 71 locations
• Investigating Epilepsy: Screening and Evaluation
  NCT03478852 · Phase: Not specified · Ages: 8 Years to 110 Years · Sex: All (male and female) · 1 location
• Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
  NCT02216500 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 50 Years · Sex: All (male and female) · 1 location
• LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
  NCT07234695 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · 5 locations
• Modulating Movement Intention Via Cortical Stimulation
  NCT03233399 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Pharmacological Modulation of Brain Oscillations in Memory Processing
  NCT05594017 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Predisposing Factors for Post-stroke Epilepsy
  NCT05864547 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
  NCT07130786 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
  NCT04076449 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Seizures often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Seizures trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.